Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea

• Päätekijät: Hye-Young Kim (Tekijä), Seong-Beom Park (Tekijä), Eun-Sil Kang (Tekijä), Sang-Min Lee (Tekijä), Hyun-Jin Kim (Tekijä), Matt Wasserman (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Taylor & Francis Group, 2021-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Introduction Globally, pneumococcal disease represents a significant burden. South Korea implemented the 7-valent pneumococcal conjugate vaccine (PCV7) in 2003, replaced with the 10-valent (PCV10) and 13-valent (PCV13) vaccine in 2010. In 2014, both vaccines were introduced in the national immunizat...